Eisai Presents New Findings on Lecanemab’s Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022
TOKYO and CAMBRIDGE, Mass., Au […]
askST: Will I lose fully vaccinated status if I don’t get third Sinovac or Sinopharm dose by Dec 31?
SINGAPORE – Those who ha […]
Covid-19 booster shots for healthcare workers, front-line workers and those 30 and above
SINGAPORE – From Saturda […]
Eisai: Fully Human Anti-TNFalpha Monoclonal Antibody HUMIRA Obtains Additional Approval
TOKYO, Sep 27, 2021 – (J […]
First batch of SAF soldiers receive Covid-19 vaccine; most to be vaccinated by mid-2021
SINGAPORE – The first ba […]